ClinVar Miner

Submissions for variant NM_006642.5(SDCCAG8):c.160A>T (p.Thr54Ser)

gnomAD frequency: 0.00009  dbSNP: rs761616528
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000823510 SCV000964371 uncertain significance Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 2022-10-24 criteria provided, single submitter clinical testing This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 54 of the SDCCAG8 protein (p.Thr54Ser). This variant is present in population databases (rs761616528, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with SDCCAG8-related conditions. ClinVar contains an entry for this variant (Variation ID: 665268). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SDCCAG8 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV003344078 SCV004051709 uncertain significance Inborn genetic diseases 2023-07-27 criteria provided, single submitter clinical testing The c.160A>T (p.T54S) alteration is located in exon 2 (coding exon 2) of the SDCCAG8 gene. This alteration results from a A to T substitution at nucleotide position 160, causing the threonine (T) at amino acid position 54 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV003396457 SCV004112015 uncertain significance SDCCAG8-related condition 2023-12-05 criteria provided, single submitter clinical testing The SDCCAG8 c.160A>T variant is predicted to result in the amino acid substitution p.Thr54Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0085% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.